This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Long Term Outcome After Ahmed Glaucoma Valve

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Dr. Karin Pillunat, Dresden University of Technology
ClinicalTrials.gov Identifier:
NCT01741961
First received: November 22, 2012
Last updated: December 3, 2012
Last verified: December 2012
  Purpose
Long term results after Ahmed glaucoma valve implantation for uncontrolled glaucoma are retrospectively examined.

Condition Intervention
Glaucoma Procedure: Ahmed valve

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Retrospective
Official Title: 4-year Follow-up After Ahmed Glaucoma Valve Implantation for Lowering Intraocular Pressure in Different Types of Glaucoma

Resource links provided by NLM:


Further study details as provided by Dr. Karin Pillunat, Dresden University of Technology:

Primary Outcome Measures:
  • intraocular pressure reduction [ Time Frame: 4 years ]
    The reduction of intraocular pressure after Ahmed glaucoma valve implantation is observed over a period of 4 years.


Secondary Outcome Measures:
  • development of visual acuity [ Time Frame: 4 years ]
    The development of visual acuity after Ahmed glaucoma valve implantation is being examined over a period of 4 years.


Other Outcome Measures:
  • reduction of glaucoma medication [ Time Frame: 4 years ]
    The number of glaucoma medication after Ahmed glaucoma valve implantation are being examined over a period of 4 years.

  • postoperative complications [ Time Frame: 4 years ]
    Possible postoperative complications after Ahmed glaucoma valve implantation are being examined over a period of 4 years.

  • need for revision operation [ Time Frame: 4 years ]
    The need for revision operations after Ahmed glaucoma valve implantation is being examined over a period of 4 years.


Enrollment: 214
Study Start Date: June 2006
Study Completion Date: October 2012
Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
glaucoma, surgery, Ahmed valve
Patients with uncontrolled glaucoma undergoing Ahmed glaucoma valve implantation for intraocular pressure reduction.
Procedure: Ahmed valve
The flexible plate 7 (FP7) model (New World Medical) was implanted in patients with uncontrolled glaucoma.

Detailed Description:
The development of intraocular pressure, visual acuity, number of glaucoma medication, number of complications and necessity of revision operations after Ahmed glaucoma valve implantation for uncontrolled glaucoma is examined yearly for a period of 4 years.
  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients suffering from uncontrolled glaucoma, most often after multiple ocular surgery.
Criteria

Inclusion Criteria:

  • Patients suffering from medically uncontrolled glaucoma
  • Informed consent

Exclusion Criteria:

  • healthy subjects
  • under 18 years
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01741961

Locations
Germany
University Eye Clinic Dresden
Dresden, Saxony, Germany, 01307
Sponsors and Collaborators
Technische Universität Dresden
Investigators
Principal Investigator: Karin R Pillunat, MD University Dresden, Eye Clinic
  More Information

Additional Information:
Responsible Party: Dr. Karin Pillunat, Principal Investigator, Dresden University of Technology
ClinicalTrials.gov Identifier: NCT01741961     History of Changes
Other Study ID Numbers: Ahmed-LTO
Study First Received: November 22, 2012
Last Updated: December 3, 2012

Keywords provided by Dr. Karin Pillunat, Dresden University of Technology:
uncontrolled glaucoma
glaucoma drainage device

Additional relevant MeSH terms:
Glaucoma
Ocular Hypertension
Eye Diseases

ClinicalTrials.gov processed this record on September 19, 2017